Genworth stock hits 52-week high at 7.91 USD

Published 23/06/2025, 20:40
Genworth stock hits 52-week high at 7.91 USD

Genworth Financial Inc (NYSE:GNW). stock reached a 52-week high of $7.91, marking a significant milestone for the company. According to InvestingPro data, the company maintains strong financial health with a current ratio of 11.93, indicating excellent liquidity, and trades at an attractive Price/Book multiple of 0.37. Over the past year, the stock has experienced a notable increase of 29.3%, reflecting strong investor confidence and positive market conditions. This uptick in stock value highlights the company’s robust performance and strategic initiatives that have resonated well with shareholders. InvestingPro analysis reveals management has been aggressively buying back shares, demonstrating confidence in the company’s outlook. The achievement of this 52-week high underscores Genworth’s resilience in navigating the financial landscape and its potential for future growth. For deeper insights and 8 additional ProTips, explore Genworth’s comprehensive Pro Research Report, available exclusively on InvestingPro.

In other recent news, Genworth Financial reported its first-quarter earnings for 2025, which showed a notable shortfall in earnings per share (EPS). The company posted an EPS of $0.12, falling short of the forecasted $0.18. However, Genworth’s revenue for the quarter reached $1.79 billion. Enact Mortgage Insurance, a significant contributor to Genworth’s performance, reported $137 million in adjusted operating income, marking a 2% year-over-year growth in primary insurance in force. Despite the earnings miss, Genworth continues its share repurchase program, having spent $55 million year-to-date. The company plans to invest $45-50 million in CareScout services in 2025 and allocate $100-120 million to share repurchases. Analysts have not provided any recent upgrades or downgrades for Genworth. Additionally, the company is facing ongoing litigation with AXA, which may have financial implications.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.